The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo
Sign Up to like & getrecommendations! Published in 2018 at "Particle and Fibre Toxicology"
DOI: 10.1186/s12989-018-0241-9
Abstract: BackgroundNanoparticles (NPs) administered orally will meet the gut microbiota, but their impacts on microbiota homeostasis and the consequent physiological relevance remain largely unknown. Here, we describe the modulatory effects and the consequent pharmacological outputs of… read more here.
Keywords: fullerenol nanoparticles; microbiota; antihyperlipidemic effects; gut microbiota ... See more keywords